HEORサービスの世界市場

HEORサービスの世界市場は2030年までに25億米ドルに達する

2024年に13億米ドルと推定されるHEORサービスの世界市場は、2024年から2030年にかけてCAGR 12.3%で成長し、2030年には25億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経済モデリング／評価サービスは、CAGR 10.3％を記録し、分析期間終了時には9億1,560万米ドルに達すると予測されます。実世界データ分析・情報システムサービス分野の成長率は、分析期間中CAGR13.0%と推定されます。

米国市場は推定3億4,350万米ドル、中国はCAGR16.2%で成長予測

米国のHEORサービス市場は、2024年に3億4,350万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを16.2%として、2030年までに5億2,110万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.1%と10.8%と予測されています。欧州では、ドイツがCAGR約9.7%で成長すると予測されています。

世界のHEORサービス市場- 主要動向と促進要因のまとめ

HEORサービスがヘルスケアの意思決定に欠かせなくなった理由とは？

医療経済・アウトカム調査（HEOR）サービスは、製薬会社、支払者、規制機関が治療の経済的価値と実世界への影響を評価するのに役立ち、ヘルスケアの意思決定において重要な要素となっています。これらのサービスは、医療介入の費用対効果、安全性、質に関するデータ主導の洞察を提供し、利害関係者が十分な情報に基づいた償還と価格決定を行えるようにします。医療費の高騰やバリュー・ベース・ケアの重要性が高まる中、HEORサービスは薬価戦略、フォーミュラリー配置、患者アクセス・プログラムの決定において重要な役割を担っています。さらに、FDAやEMAなどの規制機関は、新薬承認や市販後調査の評価にHEORデータをますます利用するようになっています。ヘルスケアシステムがエビデンスに基づく医療へとシフトする中、HEORサービスの需要は増加の一途をたどっています。

技術の進歩はHEORサービスをどのように強化していますか？

人工知能、ビッグデータ分析、リアルワールドエビデンス（RWE）プラットフォームなどの技術の進歩が、HEORの状況を変えつつあります。AIによる予測モデリングは、治療結果や費用対効果のより正確な予測を可能にしています。電子カルテ（EHR）とウェアラブルデバイスデータの統合は、より包括的な健康アウトカム評価を可能にし、リアルワールドエビデンス生成を向上させています。ブロックチェーン技術も、HEOR研究におけるデータの安全性と透明性を高めるために研究されています。さらに、ヘルスインフォマティクスの進歩により、より迅速で効率的なデータ処理が可能になり、ヘルスケアの意思決定に必要な洞察の生成に要する時間が短縮されています。このような技術革新により、HEORサービスは、ヘルスケア政策や投資の意思決定を導く上で、より正確で、拡張性があり、インパクトのあるものとなっています。

なぜ製薬会社でHEORサービスの需要が高まっているのか？

製薬会社は、複雑な価格設定や償還の状況をナビゲートし、市場参入戦略を最適化し、自社製品の価値をヘルスケア支払者に示すために、HEORサービスへの依存度を高めています。個別化医療やスペシャリティ医薬品が重視されるようになったことで、革新的な治療法が利用しやすく、手頃な価格で提供され続けるよう、しっかりとした医療経済評価の必要性が高まっています。さらに、製薬企業が競合他社から自社製品を差別化するために、比較有効性調査を実施することが不可欠になっています。バイオシミラーや遺伝子治療の拡大は、企業がプレミアム価格モデルを正当化しようとするため、HEOR主導型評価の必要性をさらに高めています。これらの要因が、HEORサービス市場の大幅な成長を後押ししています。

HEORサービス市場の成長を促す主な要因とは？

HEORサービス市場の成長の原動力となっているのは、ヘルスケア支出の増加、リアルワールドエビデンスに対する規制要件の増加、データ分析の進歩です。価値ベースのヘルスケアモデルへの移行は、経済的およびアウトカム調査の需要を増大させ、治療が臨床的および経済的な利益をもたらすことを確実にしています。さらに、新興市場におけるヘルスケア・インフラの拡大は、政府がヘルスケア支出の最適化を求める中、HEORサービス・プロバイダーに新たな機会をもたらしています。臨床試験の増加と市販後調査の必要性は、市場の拡大にさらに拍車をかけています。ヘルスケアシステムがデータ主導型になるにつれ、HEORサービスは医薬品開発、価格設定、償還戦略の形成において極めて重要な役割を果たすようになるでしょう。

セグメント

サービス（経済モデリング／評価サービス、実データ分析／情報システムサービス、臨床結果サービス、市場アクセスソリューション／償還サービス、その他サービス）;サービスプロバイダー（コンサルタントサービスプロバイダー、開発業務受託機関サービスプロバイダー）;エンドユーザー（ヘルスケアプロバイダエンドユーザー、ヘルスケアペイヤーエンドユーザー、バイオテクノロジー／製薬企業エンドユーザー、政府機関エンドユーザー、その他エンドユーザー）

調査対象企業の例

• Adelphi Values
• Artia Solutions
• Avalere Health
• Avalon Health Economics
• Axtria, Inc.
• Boston Strategic Partners
• EVERSANA
• Health Research and Analysis（HRA）
• Hull Associates
• ICON plc
• Informa plc
• IQVIA
• Lindus Health
• McKesson Corporation
• Medlior Health Outcomes Research Ltd.
• Optum, Inc.（UnitedHealth Group）
• PharmaLex GmbH
• Picnic Health
• Syneos Health
• Wellth

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global HEOR Services Market to Reach US$2.5 Billion by 2030

The global market for HEOR Services estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 12.3% over the analysis period 2024-2030. Economic Modelling / Evaluation Service, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$915.6 Million by the end of the analysis period. Growth in the Real-World Data Analysis & Information Systems Service segment is estimated at 13.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$343.5 Million While China is Forecast to Grow at 16.2% CAGR

The HEOR Services market in the U.S. is estimated at US$343.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$521.1 Million by the year 2030 trailing a CAGR of 16.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global HEOR Services Market - Key Trends & Drivers Summarized

Why Are HEOR Services Becoming Essential in Healthcare Decision-Making?

Health Economics and Outcomes Research (HEOR) services have become a critical component of healthcare decision-making, helping pharmaceutical companies, payers, and regulatory bodies assess the economic value and real-world impact of medical treatments. These services provide data-driven insights on the cost-effectiveness, safety, and quality of healthcare interventions, ensuring that stakeholders make informed reimbursement and pricing decisions. With rising healthcare costs and the growing emphasis on value-based care, HEOR services play a crucial role in determining drug pricing strategies, formulary placements, and patient access programs. Additionally, regulatory agencies such as the FDA and EMA are increasingly relying on HEOR data to evaluate new drug approvals and post-market surveillance. As healthcare systems shift toward evidence-based medicine, the demand for HEOR services continues to grow.

How Are Technological Advancements Enhancing HEOR Services?

Technological advancements, including artificial intelligence, big data analytics, and real-world evidence (RWE) platforms, are transforming the HEOR landscape. AI-driven predictive modeling is enabling more accurate forecasting of treatment outcomes and cost-effectiveness. The integration of electronic health records (EHRs) and wearable device data is improving real-world evidence generation, allowing for more comprehensive health outcome assessments. Blockchain technology is also being explored to enhance data security and transparency in HEOR studies. Additionally, advancements in health informatics are enabling faster and more efficient data processing, reducing the time required to generate insights for healthcare decision-making. These innovations are making HEOR services more precise, scalable, and impactful in guiding healthcare policy and investment decisions.

Why Is Demand for HEOR Services Increasing Among Pharmaceutical Companies?

Pharmaceutical companies are increasingly relying on HEOR services to navigate complex pricing and reimbursement landscapes, optimize market access strategies, and demonstrate the value of their products to healthcare payers. The growing emphasis on personalized medicine and specialty drugs has heightened the need for robust health economic assessments, ensuring that innovative therapies remain accessible and affordable. Additionally, HEOR services are becoming essential in conducting comparative effectiveness research, helping pharmaceutical firms differentiate their products from competitors. The expansion of biosimilars and gene therapies has further increased the need for HEOR-driven evaluations, as companies seek to justify premium pricing models. These factors are driving substantial growth in the HEOR services market.

What Are the Key Factors Driving the Growth of the HEOR Services Market?

The growth in the HEOR services market is driven by rising healthcare expenditures, increasing regulatory requirements for real-world evidence, and advancements in data analytics. The transition toward value-based healthcare models has amplified the demand for economic and outcomes research, ensuring that treatments provide both clinical and financial benefits. Additionally, the expansion of healthcare infrastructure in emerging markets is creating new opportunities for HEOR service providers, as governments seek to optimize healthcare spending. The growing number of clinical trials and the need for post-market surveillance are further fueling market expansion. As healthcare systems become more data-driven, HEOR services will continue to play a pivotal role in shaping drug development, pricing, and reimbursement strategies.

SCOPE OF STUDY:

The report analyzes the HEOR Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service, Other Services); Service Provider (Consultancy Service Provider, Contract Research Organizations Service Provider); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Adelphi Values
• Artia Solutions
• Avalere Health
• Avalon Health Economics
• Axtria, Inc.
• Boston Strategic Partners
• EVERSANA
• Health Research and Analysis (HRA)
• Hull Associates
• ICON plc
• Informa plc
• IQVIA
• Lindus Health
• McKesson Corporation
• Medlior Health Outcomes Research Ltd.
• Optum, Inc. (UnitedHealth Group)
• PharmaLex GmbH
• Picnic Health
• Syneos Health
• Wellth

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • HEOR Services - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Real-World Evidence and Data Drives Growth in HEOR Services
  • Regulatory Push for Value-Based Healthcare Models Strengthens the Business Case for HEOR Services
  • Expansion of Market Access Strategies and Reimbursement Processes Spurs the Need for HEOR Analysis
  • Integration of HEOR into Pharmaceutical and Biotech Product Development Strengthens Market Opportunities
  • Rising Pressure to Demonstrate Cost-Effectiveness and Return on Investment in Healthcare Drives HEOR Adoption
  • Technological Advancements in Data Analytics and AI Propel HEOR Service Innovation
  • Increased Focus on Patient-Centered Care Models Drives Demand for HEOR Insights on Treatment Outcomes
  • Growing Healthcare Digitization Expands Addressable Market Opportunity for HEOR Service Providers
  • The Need for Comparative Effectiveness Research to Optimize Treatment Options Fuels HEOR Market Growth
  • Emergence of Personalized Medicine and Targeted Therapies Strengthens the Case for HEOR in Clinical Decision-Making
  • Government and Payer Initiatives to Promote Cost Control and Transparency Accelerate Demand for HEOR Services
  • HEOR's Role in Supporting Regulatory Approvals for New Drug Market Entry Spurs Adoption Across Pharma
  • Advances in Health Economics Modeling Techniques Drive the Demand for Sophisticated HEOR Services
  • Rising Demand for Post-Market Surveillance Data to Monitor Long-Term Health Outcomes Expands HEOR Opportunities
  • Increased Adoption of Value-Based Contracts and Risk-Sharing Models Accelerates Demand for HEOR Solutions
  • Rising Focus on Chronic Disease Management and Prevention Drives the Need for Robust HEOR Analysis
  • Strategic Partnerships Between HEOR Providers and Healthcare Institutions Foster Growth in the Sector
  • The Shift Toward Patient-Reported Outcomes and Real-World Data Supports HEOR's Growing Relevance
  • Global Expansion of Healthcare Markets, Especially in Emerging Economies, Increases Demand for HEOR Services
  • Healthcare Policy Changes and Reforms Demand the Integration of HEOR into Healthcare Planning and Decision-Making
  • Increasing Focus on Sustainability and Environmental Impact in Healthcare Drives HEOR Innovation
  • Customization of HEOR Models for Specific Therapeutic Areas Spurs Market Segmentation and Growth
  • Healthcare Reimbursement and Pricing Pressures Drive the Need for More Comprehensive HEOR Analysis
  • Adoption of Digital Health Platforms and Telemedicine Expands Opportunities for HEOR in Remote Patient Monitoring
  • Global Health Crises and Pandemics Heighten the Need for HEOR to Evaluate Emergency Response Strategies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World HEOR Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for HEOR Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for HEOR Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for HEOR Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Economic Modelling / Evaluation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Economic Modelling / Evaluation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Economic Modelling / Evaluation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Real-World Data Analysis & Information Systems Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Real-World Data Analysis & Information Systems Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Real-World Data Analysis & Information Systems Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Clinical Outcome Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Clinical Outcome Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Clinical Outcome Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Market Access Solutions & Reimbursement Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Market Access Solutions & Reimbursement Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Market Access Solutions & Reimbursement Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Biotech / Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Biotech / Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Biotech / Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Government Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Government Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Government Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Consultancy Service Provider by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Consultancy Service Provider by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Consultancy Service Provider by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Contract Research Organizations Service Provider by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Contract Research Organizations Service Provider by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Contract Research Organizations Service Provider by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• JAPAN
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• CHINA
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• EUROPE
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for HEOR Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for HEOR Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for HEOR Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• FRANCE
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• GERMANY
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for HEOR Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for HEOR Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• AUSTRALIA
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• INDIA
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for HEOR Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for HEOR Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for HEOR Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for HEOR Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for HEOR Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for HEOR Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030
• AFRICA
  • HEOR Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for HEOR Services by Service - Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for HEOR Services by Service - Percentage Breakdown of Value Sales for Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service and Other Services for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for HEOR Services by End-Use - Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for HEOR Services by End-Use - Percentage Breakdown of Value Sales for Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses, Healthcare Providers End-Use and Healthcare Payers End-Use for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for HEOR Services by Service Provider - Consultancy Service Provider and Contract Research Organizations Service Provider Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for HEOR Services by Service Provider - Percentage Breakdown of Value Sales for Consultancy Service Provider and Contract Research Organizations Service Provider for the Years 2015, 2025 & 2030

IV. COMPETITION